Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jure Murgic
Affiliation
University Hospital Center Sestre Milosrdnice
ORCID
Career Start Year
2008
Papers
54
H Index
12
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37414620
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Clin Genitourin Cancer
2023
37389960
Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16.
Biomol Biomed
2023
32605887
Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer.
Eur Urol Oncol
2022
35718075
A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients.
Pract Radiat Oncol
2022
35778337
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
2022
36938555
ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER.
Acta Clin Croat
2022
36938553
RECENT ADVANCES IN RADIOTHERAPY MODALITIES FOR PROSTATE CANCER.
Acta Clin Croat
2022
36938552
MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.
Acta Clin Croat
2022
36938551
DOSIMETRIC VERIFICATION OF INTENSITY MODULATED RADIOTHERAPY (IMRT) TREATMENT PLANS FOR PROSTATE CANCER PATIENTS.
Acta Clin Croat
2022
36155169
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
2022
35101189
Radiation Therapy for Cure or Palliation: Case of the Immunosuppressed Patient With Multiple Primary Cancers and Liver Transplant.
Int J Radiat Oncol Biol Phys
2022
35205427
Alpha Satellite RNA Levels Are Upregulated in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer.
Genes (Basel)
2022
35078711
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer
2022
34597472
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
2022
33423945
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Eur Urol Oncol
2021
33556233
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
2021
34075770
New Insights into the Diagnosis, Molecular Taxonomy, and Treatment of Bladder Cancer.
Acta Med Acad
2021
34075765
Genetics of Prostate Carcinoma.
Acta Med Acad
2021
33989586
In Regard to van Son et al.
Int J Radiat Oncol Biol Phys
2021
33980277
Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.
Radiat Oncol
2021
32234933
Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage.
Anticancer Res
2020
31971495
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
J Urol
2020
32048930
Oncologist Burnout Syndrome in Eastern Europe: Results of the Multinational Survey.
JCO Oncol Pract
2020
31829450
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Cancer
2020
33220228
In Regard to Lee et al.
Int J Radiat Oncol Biol Phys
2020
31126856
Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapy.
Brachytherapy
2019
30170099
Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy.
Int J Radiat Oncol Biol Phys
2019
29239812
Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.
Brachytherapy
2018
30244878
Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.
Int J Radiat Oncol Biol Phys
2018
29249526
Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-front Radical Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys
2018
27815082
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.
Eur Urol
2017
28434799
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy.
Radiother Oncol
2017
28511883
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
Eur Urol
2017
28848661
Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?
ESMO Open
2017
26832674
Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer.
Brachytherapy
2016
27843608
Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP).
ESMO Open
2016
24064749
Time to Nadir PSA: Of Popes and PSA--The Immortality Bias.
Am J Clin Oncol
2015
25550591
Sunitinib-induced thyrotoxicosis - a not so rare entity.
Anticancer Res
2015
24922691
Hypothyroidism as a predictive clinical marker of better treatment response to sunitinib therapy.
Anticancer Res
2014
24982415
High-dose-rate brachytherapy and concurrent chemoradiotherapy followed by surgery for stage Ib-IIb cervical cancer: single institution experience.
Anticancer Res
2014
24987355
Familial adenomatous polyposis in three generations of a single family: a case study.
Case Rep Oncol
2014
24842891
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy.
J Nucl Med
2014
22522987
Breast and gynecological cancers in Croatia, 1988-2008.
Croat Med J
2012
23390830
Quality of life of Croatian breast cancer patients receiving adjuvant treatment--comparison to long-term breast cancer survivors.
Coll Antropol
2012
22852797
The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer.
Radiat Oncol
2012
22816241
Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer.
Coll Antropol
2012
21755735
Postoperative use of radioiodine (131-I): review of recommendations and guidelines.
Coll Antropol
2011
22034781
Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience.
Acta Clin Croat
2011
21888085
[Leiomyomatous renal cell carcinoma - case report].
Lijec Vjesn
2011
21755739
Radiation therapy in treatment of fibrodysplasia ossificans progressiva: a case report and review of the literature.
Coll Antropol
2011
1 - 50 of 54
Column Actions
Search
Recommended Authors
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year
2013
Number of shared co-authors
15
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
4
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year
2012
Number of shared co-authors
9
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Career Start Year
2010
Number of shared co-authors
21
Ting Martin Ma
University of Washington
Career Start Year
2010
Number of shared co-authors
6
Amar U Kishan
University of California los angeles
Career Start Year
2008
Number of shared co-authors
13
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year
2008
Number of shared co-authors
12
Bradley J Stish
Mayo Clinic
Career Start Year
2007
Number of shared co-authors
6
Bridget F Koontz
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
6
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
2006
Number of shared co-authors
4
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year
2004
Number of shared co-authors
12
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year
2004
Number of shared co-authors
10
Albert J Chang
University of California Los Angeles
Career Start Year
2003
Number of shared co-authors
7
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year
2002
Number of shared co-authors
16
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
5
Chandana A Reddy
Cleveland Clinic
Career Start Year
2000
Number of shared co-authors
6
Robert B Den
Thomas Jefferson University Hospital
Career Start Year
1999
Number of shared co-authors
19
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year
1998
Number of shared co-authors
10
Gert De Meerleer
University Hospitals Leuven
Career Start Year
1997
Number of shared co-authors
11
Phuoc T Tran
University of Maryland School of Medicine
Career Start Year
1996
Number of shared co-authors
12
Michael L Steinberg
University of California los angeles
Career Start Year
1996
Number of shared co-authors
8
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Career Start Year
1994
Number of shared co-authors
3
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year
1994
Number of shared co-authors
4
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
1993
Number of shared co-authors
0
William Robert Lee
Duke University School of Medicine
Career Start Year
1993
Number of shared co-authors
3
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year
1991
Number of shared co-authors
7
Anthony V D'Amico
Duke University Medical Center
Career Start Year
1988
Number of shared co-authors
4
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year
1987
Number of shared co-authors
4
Joseph L Chin
University of Western Ontario
Career Start Year
1982
Number of shared co-authors
9
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year
1976
Number of shared co-authors
12
row(s) 1 - 30 of 30
Collaborators
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers
9
Alexandra Drakaki
David Geffen School of Medicine at university of california los angeles
Co-authored papers
9
Neeraj Agarwal
Co-authored papers
8
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers
7
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers
7
Robert G Bristow
University of Toronto
Co-authored papers
6
Pedro Isaacsson Velho
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Co-authored papers
5
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers
4
Paul C Boutros
University of California los angeles
Co-authored papers
4
Matthew D Galsky
Co-authored papers
4
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers
4
Alice Meng
Tufts University School of Medicine
Co-authored papers
3
Jonathan L Wright
University of Washington Medical Center
Co-authored papers
3
Masoom A Haider
University Health Network
Co-authored papers
3
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
2
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Co-authored papers
2
Emilie Lalonde
University of Pennsylvania
Co-authored papers
2
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers
2
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers
2
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers
2
Neil E Fleshner
University of Toronto
Co-authored papers
2
Val??rie Picard
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers
2
Eric Lu
David Geffen School of Medicine at university of california los angeles
Co-authored papers
2
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers
2
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
2
Ali Hosni
Princess Margaret Cancer Center
Co-authored papers
2
Adriana Salcedo
University of Toronto
Co-authored papers
2
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers
2
1 - 30